Homocysteine and cardiovascular disease:: Current evidence and future prospects
- 31 May 2002
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 112 (7) , 556-565
- https://doi.org/10.1016/s0002-9343(02)01021-5
Abstract
No abstract availableKeywords
This publication has 91 references indexed in Scilit:
- Enhancement by Homocysteine of Plasminogen Activator Inhibitor-1 Gene Expression and Secretion from Vascular Endothelial and Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2000
- Plasma Homocysteine, Aortic Stiffness, and Renal Function in Hypertensive PatientsHypertension, 1999
- Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuriaKidney International, 1999
- A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.Journal of the American College of Nutrition, 1996
- Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Homocysteine and coronary artery disease in French Canadian subjects: Relation with vitamins B12, B6, pyridoxal phosphate, and folateThe American Journal of Cardiology, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.Stroke, 1994
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseNew England Journal of Medicine, 1991
- Neuropsychiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or MacrocytosisNew England Journal of Medicine, 1988